HIV 1 News and Research

RSS

Large-scale clinical trial begins to study liver transplantation between people with HIV

The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States. The HOPE in Action Multicenter Liver Study will determine the safety of this practice by evaluating liver recipients for potential transplant-related and HIV-related complications following surgery.

15 Feb 2019

Verbal autopsy interviews capture more accurate data about causes of deaths in Uganda

Training community health workers to perform verbal autopsy interviews captured more accurate and complete data about the number and causes of deaths in a rural sub-county of Uganda than current health facility-dependent surveillance methods, according to researchers at the University of North Carolina at Chapel Hill and their in-country partners.

14 Feb 2019

New bioengineered device enhances the production of T-cells

Bone marrow transplants, also known as hematopoietic stem cell transplants, are life-saving treatments for aggressive diseases, such as leukemia and multiple myeloma, and infections such as HIV. The procedure entails infusion of blood stem cells from a matched donor into the patient to 'reset' the blood and immune system.

12 Feb 2019

New measurable indicator could prove instrumental in fight against HIV

George Mason University's Yuntao Wu is the lead scientist on a research team that has identified a measurable indicator that could prove instrumental in the fight against HIV.

11 Feb 2019

IAS 2019 plenary program spotlights urgent developments in HIV science

The International AIDS Society has announced the plenary presentations that will lead the 10th IAS Conference on HIV Science, which will take place in Mexico City, Mexico, on 21-24 July 2019. IAS 2019 is the largest open scientific conference on HIV and is expected to bring together more than 6,000 participants from more than 140 countries.

8 Feb 2019

New clinical trial aims to examine safety and use of two HIV prevention tools

A clinical trial has begun to examine the safety and use of two HIV prevention tools--oral pre-exposure prophylaxis and a vaginal ring--in adolescent girls and young women in southern Africa.

8 Feb 2019

MTN launches new study to empower teen girls with choices in HIV prevention

AIDS is already the leading cause of death among girls and young women in much of Africa, and matters could only get worse, given that for every day that passes, 1,000 more girls ages 15 to 24 are likely to become infected with HIV.

8 Feb 2019

Researchers develop intervention to encourage couples HIV testing

It's long been known that couples HIV testing and counseling is an effective way to mutually disclose HIV status and link to health care--unfortunately, couples don't use it even though it's widely available.

8 Feb 2019

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Health policy played a surprisingly robust role in President Donald Trump's 2019 State of the Union address.

7 Feb 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

UNC-led scientists receive $5.1 million grant to combat cervical cancer in Malawi

Backed by a $5.1 million grant, University of North Carolina and University of Malawi College of Medicine physicians and scientists will launch a multi-pronged effort to combat cervical cancer in Malawi, a country in sub-Saharan Africa where cervical cancer is the leading cause of cancer death among women.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Noting that science has "brought a once-distant dream within reach," President Donald Trump on Tuesday night pledged to eliminate HIV transmission within 10 years.

6 Feb 2019

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

It was not the centerpiece, but health was a persistent theme in President Donald Trump's State of the Union address at the Capitol on Tuesday night.

6 Feb 2019

HIV-1 protein plays broader role in suppressing immune response than thought

Scientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection than previously thought.

6 Feb 2019

Researchers harness immune system to reveal new clues to produce HIV vaccine

The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.

4 Feb 2019

New research may help treat HIV patients without elevating risk for liver disease

As a raft of new treatments for HIV infection have come on the market in the past 20 years, AIDS patients got access to drugs that allowed them to live longer.

1 Feb 2019

NIH-funded researchers develop new assay to measure success of HIV cure strategies

Scientists funded by the National Institutes of Health have developed a new assay to accurately and easily count the cells that comprise the HIV reservoir, the stubborn obstacle to an HIV cure.

31 Jan 2019

Experts highlight emerging evidence of impending Parkinson’s disease pandemic

For most of human history Parkinson's disease (PD) has been a rare disorder. However, demography and the by-products of industrialization a now contributing to an impending a Parkinson's pandemic, according to experts writing in a supplement to the Journal of Parkinson's Disease.

29 Jan 2019

New research collaboration between EU and Russia focuses on infectious diseases

A new EU project on the theme of HIV, hepatitis C and tuberculosis is a door opener for collaboration between researchers from EU countries and Russia.

28 Jan 2019